APO Research
Talk to an analyst

APO RESEARCH · REPORT

Purpura Therapy Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Purpura Therapy Drugs Market Outlook and Growth Opportunities 2026

23 December 2025202 pages

Choose your research edition.

Industry ResearchPurpura Therapy Drugs Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Purpura Therapy Drugs Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Purpura Therapy Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Purpura Therapy Drugs Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Purpura Therapy Drugs Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Purpura Therapy Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Purpura Therapy Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Purpura Therapy Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Purpura Therapy Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Purpura Therapy Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Purpura Therapy Drugs market include Ablynx NV, Bristol-Myers Squibb Company, Grifols Biologicals Inc, Hoffman-L Roche, Hovione, KM Biologics, Lee's Pharmaceutical Holdings Ltd, Omeros Corp and Pfizer Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Purpura Therapy Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Purpura Therapy Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Purpura Therapy Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Purpura Therapy Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Purpura Therapy Drugs Segment by Company

Ablynx NV

Bristol-Myers Squibb Company

Grifols Biologicals Inc

Hoffman-L Roche

Hovione

KM Biologics

Lee's Pharmaceutical Holdings Ltd

Omeros Corp

Pfizer Inc

Roch

Sanofi Winthrop Industrie S.A.

Amgen Inc

Biogen Inc

GlaxoSmithKline Plc

Novartis AG

Takeda

Purpura Therapy Drugs Segment by Type

Allergic Purpura

Thrombocytopenic Purpura

Purpura Therapy Drugs Segment by Application

Hospital Use

Clinic Use

Household

Others

Purpura Therapy Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Purpura Therapy Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Purpura Therapy Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Purpura Therapy Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Purpura Therapy Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Purpura Therapy Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Purpura Therapy Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Purpura Therapy Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Purpura Therapy Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Purpura Therapy Drugs industry.

Chapter 3: Detailed analysis of Purpura Therapy Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Purpura Therapy Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Purpura Therapy Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Purpura Therapy Drugs Industry Trends Table 2. Purpura Therapy Drugs Industry Drivers Table 3. Purpura Therapy Drugs Industry Opportunities and Challenges Table 4. Purpura Therapy Drugs Industry Restraints Table 5. Global Purpura Therapy Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Purpura Therapy Drugs Revenue Share by Company (2021-2026) Table 7. Global Purpura Therapy Drugs Sales Volume by Company (k pcs) & (2021-2026) Table 8. Global Purpura Therapy Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Purpura Therapy Drugs Average Price (US$/pcs) of Company (2021-2026) Table 10. Global Purpura Therapy Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Purpura Therapy Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Purpura Therapy Drugs Company, Product Type & Application Table 13. Global Purpura Therapy Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Purpura Therapy Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Allergic Purpura Table 18. Significant Companies of Thrombocytopenic Purpura Table 19. Global Purpura Therapy Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (k pcs) Table 20. Global Purpura Therapy Drugs Sales Volume by Type (2021-2026) & (k pcs) Table 21. Global Purpura Therapy Drugs Sales Volume by Type (2027-2032) & (k pcs) Table 22. Global Purpura Therapy Drugs Sales Volume Share by Type (2021-2026) Table 23. Global Purpura Therapy Drugs Sales Volume Share by Type (2027-2032) Table 24. Global Purpura Therapy Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Purpura Therapy Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Purpura Therapy Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Purpura Therapy Drugs Sales Value Share by Type (2021-2026) Table 28. Global Purpura Therapy Drugs Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Use Table 30. Significant Companies of Clinic Use Table 31. Significant Companies of Household Table 32. Significant Companies of Others Table 33. Global Purpura Therapy Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (k pcs) Table 34. Global Purpura Therapy Drugs Sales Volume by Application (2021-2026) & (k pcs) Table 35. Global Purpura Therapy Drugs Sales Volume by Application (2027-2032) & (k pcs) Table 36. Global Purpura Therapy Drugs Sales Volume Share by Application (2021-2026) Table 37. Global Purpura Therapy Drugs Sales Volume Share by Application (2027-2032) Table 38. Global Purpura Therapy Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Purpura Therapy Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Purpura Therapy Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Purpura Therapy Drugs Sales Value Share by Application (2021-2026) Table 42. Global Purpura Therapy Drugs Sales Value Share by Application (2027-2032) Table 43. Global Purpura Therapy Drugs Sales by Region: 2021 VS 2025 VS 2032 (k pcs) Table 44. Global Purpura Therapy Drugs Sales by Region (2021-2026) & (k pcs) Table 45. Global Purpura Therapy Drugs Sales Market Share by Region (2021-2026) Table 46. Global Purpura Therapy Drugs Sales by Region (2027-2032) & (k pcs) Table 47. Global Purpura Therapy Drugs Sales Market Share by Region (2027-2032) Table 48. Global Purpura Therapy Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Purpura Therapy Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Purpura Therapy Drugs Sales Value Share by Region (2021-2026) Table 51. Global Purpura Therapy Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Purpura Therapy Drugs Sales Value Share by Region (2027-2032) Table 53. Global Purpura Therapy Drugs Market Average Price (US$/pcs) by Region (2021-2026) Table 54. Global Purpura Therapy Drugs Market Average Price (US$/pcs) by Region (2027-2032) Table 55. Global Purpura Therapy Drugs Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Table 56. Global Purpura Therapy Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Purpura Therapy Drugs Sales by Country (2021-2026) & (k pcs) Table 58. Global Purpura Therapy Drugs Sales Market Share by Country (2021-2026) Table 59. Global Purpura Therapy Drugs Sales by Country (2027-2032) & (k pcs) Table 60. Global Purpura Therapy Drugs Sales Market Share by Country (2027-2032) Table 61. Global Purpura Therapy Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Purpura Therapy Drugs Sales Value Market Share by Country (2021-2026) Table 63. Global Purpura Therapy Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Purpura Therapy Drugs Sales Value Market Share by Country (2027-2032) Table 65. Ablynx NV Company Information Table 66. Ablynx NV Business Overview Table 67. Ablynx NV Purpura Therapy Drugs Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 68. Ablynx NV Purpura Therapy Drugs Product Portfolio Table 69. Ablynx NV Recent Development Table 70. Bristol-Myers Squibb Company Company Information Table 71. Bristol-Myers Squibb Company Business Overview Table 72. Bristol-Myers Squibb Company Purpura Therapy Drugs Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 73. Bristol-Myers Squibb Company Purpura Therapy Drugs Product Portfolio Table 74. Bristol-Myers Squibb Company Recent Development Table 75. Grifols Biologicals Inc Company Information Table 76. Grifols Biologicals Inc Business Overview Table 77. Grifols Biologicals Inc Purpura Therapy Drugs Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 78. Grifols Biologicals Inc Purpura Therapy Drugs Product Portfolio Table 79. Grifols Biologicals Inc Recent Development Table 80. Hoffman-L Roche Company Information Table 81. Hoffman-L Roche Business Overview Table 82. Hoffman-L Roche Purpura Therapy Drugs Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 83. Hoffman-L Roche Purpura Therapy Drugs Product Portfolio Table 84. Hoffman-L Roche Recent Development Table 85. Hovione Company Information Table 86. Hovione Business Overview Table 87. Hovione Purpura Therapy Drugs Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 88. Hovione Purpura Therapy Drugs Product Portfolio Table 89. Hovione Recent Development Table 90. KM Biologics Company Information Table 91. KM Biologics Business Overview Table 92. KM Biologics Purpura Therapy Drugs Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 93. KM Biologics Purpura Therapy Drugs Product Portfolio Table 94. KM Biologics Recent Development Table 95. Lee's Pharmaceutical Holdings Ltd Company Information Table 96. Lee's Pharmaceutical Holdings Ltd Business Overview Table 97. Lee's Pharmaceutical Holdings Ltd Purpura Therapy Drugs Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 98. Lee's Pharmaceutical Holdings Ltd Purpura Therapy Drugs Product Portfolio Table 99. Lee's Pharmaceutical Holdings Ltd Recent Development Table 100. Omeros Corp Company Information Table 101. Omeros Corp Business Overview Table 102. Omeros Corp Purpura Therapy Drugs Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 103. Omeros Corp Purpura Therapy Drugs Product Portfolio Table 104. Omeros Corp Recent Development Table 105. Pfizer Inc Company Information Table 106. Pfizer Inc Business Overview Table 107. Pfizer Inc Purpura Therapy Drugs Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 108. Pfizer Inc Purpura Therapy Drugs Product Portfolio Table 109. Pfizer Inc Recent Development Table 110. Roch Company Information Table 111. Roch Business Overview Table 112. Roch Purpura Therapy Drugs Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 113. Roch Purpura Therapy Drugs Product Portfolio Table 114. Roch Recent Development Table 115. Sanofi Winthrop Industrie S.A. Company Information Table 116. Sanofi Winthrop Industrie S.A. Business Overview Table 117. Sanofi Winthrop Industrie S.A. Purpura Therapy Drugs Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 118. Sanofi Winthrop Industrie S.A. Purpura Therapy Drugs Product Portfolio Table 119. Sanofi Winthrop Industrie S.A. Recent Development Table 120. Amgen Inc Company Information Table 121. Amgen Inc Business Overview Table 122. Amgen Inc Purpura Therapy Drugs Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 123. Amgen Inc Purpura Therapy Drugs Product Portfolio Table 124. Amgen Inc Recent Development Table 125. Biogen Inc Company Information Table 126. Biogen Inc Business Overview Table 127. Biogen Inc Purpura Therapy Drugs Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 128. Biogen Inc Purpura Therapy Drugs Product Portfolio Table 129. Biogen Inc Recent Development Table 130. GlaxoSmithKline Plc Company Information Table 131. GlaxoSmithKline Plc Business Overview Table 132. GlaxoSmithKline Plc Purpura Therapy Drugs Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 133. GlaxoSmithKline Plc Purpura Therapy Drugs Product Portfolio Table 134. GlaxoSmithKline Plc Recent Development Table 135. Novartis AG Company Information Table 136. Novartis AG Business Overview Table 137. Novartis AG Purpura Therapy Drugs Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 138. Novartis AG Purpura Therapy Drugs Product Portfolio Table 139. Novartis AG Recent Development Table 140. Takeda Company Information Table 141. Takeda Business Overview Table 142. Takeda Purpura Therapy Drugs Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 143. Takeda Purpura Therapy Drugs Product Portfolio Table 144. Takeda Recent Development Table 145. Key Raw Materials Table 146. Raw Materials Key Suppliers Table 147. Purpura Therapy Drugs Distributors List Table 148. Purpura Therapy Drugs Customers List Table 149. Research Programs/Design for This Report Table 150. Authors List of This Report Table 151. Secondary Sources Table 152. Primary Sources List of Figures Figure 1. Purpura Therapy Drugs Product Image Figure 2. Global Purpura Therapy Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Purpura Therapy Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Purpura Therapy Drugs Sales (2021-2032) & (k pcs) Figure 5. Global Purpura Therapy Drugs Sales Average Price (US$/pcs) & (2021-2032) Figure 6. Global Purpura Therapy Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Allergic Purpura Image Figure 10. Thrombocytopenic Purpura Image Figure 11. Global Purpura Therapy Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (k pcs) Figure 12. Global Purpura Therapy Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Purpura Therapy Drugs Sales Volume Share by Type (2021-2032) Figure 14. Global Purpura Therapy Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Purpura Therapy Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Purpura Therapy Drugs Sales Value Share by Type (2021-2032) Figure 17. Hospital Use Image Figure 18. Clinic Use Image Figure 19. Household Image Figure 20. Others Image Figure 21. Global Purpura Therapy Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (k pcs) Figure 22. Global Purpura Therapy Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Purpura Therapy Drugs Sales Volume Share by Application (2021-2032) Figure 24. Global Purpura Therapy Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Purpura Therapy Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Purpura Therapy Drugs Sales Value Share by Application (2021-2032) Figure 27. Global Purpura Therapy Drugs Sales by Region: 2021 VS 2025 VS 2032 (k pcs) Figure 28. Global Purpura Therapy Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Purpura Therapy Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Purpura Therapy Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Purpura Therapy Drugs Sales Value (2021-2032) & (US$ Million) Figure 32. North America Purpura Therapy Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Purpura Therapy Drugs Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Purpura Therapy Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Purpura Therapy Drugs Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Purpura Therapy Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Purpura Therapy Drugs Sales Value (2021-2032) & (US$ Million) Figure 38. South America Purpura Therapy Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Purpura Therapy Drugs Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Purpura Therapy Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Purpura Therapy Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Purpura Therapy Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Purpura Therapy Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Purpura Therapy Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Purpura Therapy Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Purpura Therapy Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Purpura Therapy Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Purpura Therapy Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Purpura Therapy Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Purpura Therapy Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Purpura Therapy Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Purpura Therapy Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Purpura Therapy Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Purpura Therapy Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Purpura Therapy Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Purpura Therapy Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Purpura Therapy Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Purpura Therapy Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Purpura Therapy Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Purpura Therapy Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Purpura Therapy Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Purpura Therapy Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Purpura Therapy Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Purpura Therapy Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Purpura Therapy Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Purpura Therapy Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Purpura Therapy Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Purpura Therapy Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Purpura Therapy Drugs Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Purpura Therapy Drugs Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Allergic Purpura
  • Thrombocytopenic Purpura
Applications
  • Hospital Use
  • Clinic Use
  • Household
  • Others
Companies covered
  • Ablynx NV
  • Bristol-Myers Squibb Company
  • Grifols Biologicals Inc
  • Hoffman-L Roche
  • Hovione
  • KM Biologics
  • Lee's Pharmaceutical Holdings Ltd
  • Omeros Corp
  • Pfizer Inc
  • Roch
  • Sanofi Winthrop Industrie S.A.
  • Amgen Inc
  • Biogen Inc
  • GlaxoSmithKline Plc
  • Novartis AG
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Purpura Therapy Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Purpura Therapy Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Purpura Therapy Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Purpura Therapy Drugs Market Dynamics
  1. 2.1 Purpura Therapy Drugs Industry Trends
  2. 2.2 Purpura Therapy Drugs Industry Drivers
  3. 2.3 Purpura Therapy Drugs Industry Opportunities and Challenges
  4. 2.4 Purpura Therapy Drugs Industry Restraints
3 Purpura Therapy Drugs Market by Company
  1. 3.1 Global Purpura Therapy Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Purpura Therapy Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Purpura Therapy Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Purpura Therapy Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Purpura Therapy Drugs Company Ranking (2024-2026)
  6. 3.6 Global Purpura Therapy Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Purpura Therapy Drugs Company Product Type and Application
  8. 3.8 Global Purpura Therapy Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Purpura Therapy Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Purpura Therapy Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Purpura Therapy Drugs Market by Type
  1. 4.1 Purpura Therapy Drugs Type Introduction
  2. 4.1.1 Allergic Purpura
  3. 4.1.2 Thrombocytopenic Purpura
  4. 4.2 Global Purpura Therapy Drugs Sales Volume by Type
  5. 4.2.1 Global Purpura Therapy Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Purpura Therapy Drugs Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Purpura Therapy Drugs Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Purpura Therapy Drugs Sales Value by Type
  9. 4.3.1 Global Purpura Therapy Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Purpura Therapy Drugs Sales Value by Type (2021-2032)
  11. 4.3.3 Global Purpura Therapy Drugs Sales Value Share by Type (2021-2032)
5 Purpura Therapy Drugs Market by Application
  1. 5.1 Purpura Therapy Drugs Application Introduction
  2. 5.1.1 Hospital Use
  3. 5.1.2 Clinic Use
  4. 5.1.3 Household
  5. 5.1.4 Others
  6. 5.2 Global Purpura Therapy Drugs Sales Volume by Application
  7. 5.2.1 Global Purpura Therapy Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Purpura Therapy Drugs Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Purpura Therapy Drugs Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Purpura Therapy Drugs Sales Value by Application
  11. 5.3.1 Global Purpura Therapy Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Purpura Therapy Drugs Sales Value by Application (2021-2032)
  13. 5.3.3 Global Purpura Therapy Drugs Sales Value Share by Application (2021-2032)
6 Purpura Therapy Drugs Regional Sales and Value Analysis
  1. 6.1 Global Purpura Therapy Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Purpura Therapy Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Purpura Therapy Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Purpura Therapy Drugs Sales by Region (2027-2032)
  5. 6.3 Global Purpura Therapy Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Purpura Therapy Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Purpura Therapy Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Purpura Therapy Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Purpura Therapy Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Purpura Therapy Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Purpura Therapy Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Purpura Therapy Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Purpura Therapy Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Purpura Therapy Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Purpura Therapy Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Purpura Therapy Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Purpura Therapy Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Purpura Therapy Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Purpura Therapy Drugs Sales Value Share by Country, 2025 VS 2032
7 Purpura Therapy Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Purpura Therapy Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Purpura Therapy Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Purpura Therapy Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Purpura Therapy Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Purpura Therapy Drugs Sales by Country (2027-2032)
  6. 7.4 Global Purpura Therapy Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Purpura Therapy Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Purpura Therapy Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Purpura Therapy Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Purpura Therapy Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Purpura Therapy Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Purpura Therapy Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Purpura Therapy Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Purpura Therapy Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Purpura Therapy Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Purpura Therapy Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Purpura Therapy Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Purpura Therapy Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Purpura Therapy Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Purpura Therapy Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Purpura Therapy Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Purpura Therapy Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Purpura Therapy Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Purpura Therapy Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Purpura Therapy Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Purpura Therapy Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Purpura Therapy Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Purpura Therapy Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Purpura Therapy Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Purpura Therapy Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Purpura Therapy Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Purpura Therapy Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Purpura Therapy Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Purpura Therapy Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Purpura Therapy Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Purpura Therapy Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Purpura Therapy Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Purpura Therapy Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Ablynx NV
  2. 8.1.1 Ablynx NV Company Information
  3. 8.1.2 Ablynx NV Business Overview
  4. 8.1.3 Ablynx NV Purpura Therapy Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Ablynx NV Purpura Therapy Drugs Product Portfolio
  6. 8.1.5 Ablynx NV Recent Developments
  7. 8.2 Bristol-Myers Squibb Company
  8. 8.2.1 Bristol-Myers Squibb Company Company Information
  9. 8.2.2 Bristol-Myers Squibb Company Business Overview
  10. 8.2.3 Bristol-Myers Squibb Company Purpura Therapy Drugs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Bristol-Myers Squibb Company Purpura Therapy Drugs Product Portfolio
  12. 8.2.5 Bristol-Myers Squibb Company Recent Developments
  13. 8.3 Grifols Biologicals Inc
  14. 8.3.1 Grifols Biologicals Inc Company Information
  15. 8.3.2 Grifols Biologicals Inc Business Overview
  16. 8.3.3 Grifols Biologicals Inc Purpura Therapy Drugs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Grifols Biologicals Inc Purpura Therapy Drugs Product Portfolio
  18. 8.3.5 Grifols Biologicals Inc Recent Developments
  19. 8.4 Hoffman-L Roche
  20. 8.4.1 Hoffman-L Roche Company Information
  21. 8.4.2 Hoffman-L Roche Business Overview
  22. 8.4.3 Hoffman-L Roche Purpura Therapy Drugs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Hoffman-L Roche Purpura Therapy Drugs Product Portfolio
  24. 8.4.5 Hoffman-L Roche Recent Developments
  25. 8.5 Hovione
  26. 8.5.1 Hovione Company Information
  27. 8.5.2 Hovione Business Overview
  28. 8.5.3 Hovione Purpura Therapy Drugs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Hovione Purpura Therapy Drugs Product Portfolio
  30. 8.5.5 Hovione Recent Developments
  31. 8.6 KM Biologics
  32. 8.6.1 KM Biologics Company Information
  33. 8.6.2 KM Biologics Business Overview
  34. 8.6.3 KM Biologics Purpura Therapy Drugs Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 KM Biologics Purpura Therapy Drugs Product Portfolio
  36. 8.6.5 KM Biologics Recent Developments
  37. 8.7 Lee's Pharmaceutical Holdings Ltd
  38. 8.7.1 Lee's Pharmaceutical Holdings Ltd Company Information
  39. 8.7.2 Lee's Pharmaceutical Holdings Ltd Business Overview
  40. 8.7.3 Lee's Pharmaceutical Holdings Ltd Purpura Therapy Drugs Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Lee's Pharmaceutical Holdings Ltd Purpura Therapy Drugs Product Portfolio
  42. 8.7.5 Lee's Pharmaceutical Holdings Ltd Recent Developments
  43. 8.8 Omeros Corp
  44. 8.8.1 Omeros Corp Company Information
  45. 8.8.2 Omeros Corp Business Overview
  46. 8.8.3 Omeros Corp Purpura Therapy Drugs Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Omeros Corp Purpura Therapy Drugs Product Portfolio
  48. 8.8.5 Omeros Corp Recent Developments
  49. 8.9 Pfizer Inc
  50. 8.9.1 Pfizer Inc Company Information
  51. 8.9.2 Pfizer Inc Business Overview
  52. 8.9.3 Pfizer Inc Purpura Therapy Drugs Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Pfizer Inc Purpura Therapy Drugs Product Portfolio
  54. 8.9.5 Pfizer Inc Recent Developments
  55. 8.10 Roch
  56. 8.10.1 Roch Company Information
  57. 8.10.2 Roch Business Overview
  58. 8.10.3 Roch Purpura Therapy Drugs Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Roch Purpura Therapy Drugs Product Portfolio
  60. 8.10.5 Roch Recent Developments
  61. 8.11 Sanofi Winthrop Industrie S.A.
  62. 8.11.1 Sanofi Winthrop Industrie S.A. Company Information
  63. 8.11.2 Sanofi Winthrop Industrie S.A. Business Overview
  64. 8.11.3 Sanofi Winthrop Industrie S.A. Purpura Therapy Drugs Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Sanofi Winthrop Industrie S.A. Purpura Therapy Drugs Product Portfolio
  66. 8.11.5 Sanofi Winthrop Industrie S.A. Recent Developments
  67. 8.12 Amgen Inc
  68. 8.12.1 Amgen Inc Company Information
  69. 8.12.2 Amgen Inc Business Overview
  70. 8.12.3 Amgen Inc Purpura Therapy Drugs Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Amgen Inc Purpura Therapy Drugs Product Portfolio
  72. 8.12.5 Amgen Inc Recent Developments
  73. 8.13 Biogen Inc
  74. 8.13.1 Biogen Inc Company Information
  75. 8.13.2 Biogen Inc Business Overview
  76. 8.13.3 Biogen Inc Purpura Therapy Drugs Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Biogen Inc Purpura Therapy Drugs Product Portfolio
  78. 8.13.5 Biogen Inc Recent Developments
  79. 8.14 GlaxoSmithKline Plc
  80. 8.14.1 GlaxoSmithKline Plc Company Information
  81. 8.14.2 GlaxoSmithKline Plc Business Overview
  82. 8.14.3 GlaxoSmithKline Plc Purpura Therapy Drugs Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 GlaxoSmithKline Plc Purpura Therapy Drugs Product Portfolio
  84. 8.14.5 GlaxoSmithKline Plc Recent Developments
  85. 8.15 Novartis AG
  86. 8.15.1 Novartis AG Company Information
  87. 8.15.2 Novartis AG Business Overview
  88. 8.15.3 Novartis AG Purpura Therapy Drugs Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Novartis AG Purpura Therapy Drugs Product Portfolio
  90. 8.15.5 Novartis AG Recent Developments
  91. 8.16 Takeda
  92. 8.16.1 Takeda Company Information
  93. 8.16.2 Takeda Business Overview
  94. 8.16.3 Takeda Purpura Therapy Drugs Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Takeda Purpura Therapy Drugs Product Portfolio
  96. 8.16.5 Takeda Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Purpura Therapy Drugs Value Chain Analysis
  2. 9.1.1 Purpura Therapy Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Purpura Therapy Drugs Sales Mode & Process
  6. 9.2 Purpura Therapy Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Purpura Therapy Drugs Distributors
  9. 9.2.3 Purpura Therapy Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst